Early Administration of Edoxaban After Acute Ischemic Stroke in Patients With Non-valvular Atrial Fibrillation

PHASE2CompletedINTERVENTIONAL
Enrollment

68

Participants

Timeline

Start Date

June 19, 2018

Primary Completion Date

April 14, 2020

Study Completion Date

July 2, 2020

Conditions
Acute Ischemic Stroke
Interventions
DRUG

Edoxaban

"1-3-6-12 rule\*~Anticoagulation in patients with acute ischemic stroke and atrial fibrillation can be initiated from the following days after stroke event.~After 1 day: transient ischemic attacks~After 3 days: mild ischemic strokes (NIHSS \<8)~After 6 days: moderate ischemic strokes (NIHSS 8-16)~After 12 days: severe ischemic strokes (NIHSS \>16)~\- NIHSS: National Institute of Health Stroke Scales"

Trial Locations (1)

Unknown

Asan Medical Center, Seoul

All Listed Sponsors
collaborator

Kyung Hee University Hospital

OTHER

collaborator

Soon Chun Hyang University

OTHER

collaborator

Dong-A University Hospital

OTHER

lead

Jong Sung Kim

OTHER

NCT03433235 - Early Administration of Edoxaban After Acute Ischemic Stroke in Patients With Non-valvular Atrial Fibrillation | Biotech Hunter | Biotech Hunter